(Q40603313)

22 September 2017

1 reference

title

Activation of HIV-1 transcription by Tat in cells derived from the CNS: evidence for the participation of NF-kappa B--a review (English)

1 reference

22 September 2017

0 references

Taylor JP

1 reference

22 September 2017

Khalili K

series ordinal

1 reference

22 September 2017

publication date

1 January 1994

1 reference

Advances in neuroimmunology

22 September 2017

published in

1 reference

22 September 2017

1 reference

22 September 2017

1 reference

22 September 2017

page(s)

291-303

1 reference

Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-kappa B transcription factor

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980270-6

7 January 2021

I kappa B: a specific inhibitor of the NF-kappa B transcription factor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980270-6

7 January 2021

A 65-kappaD subunit of active NF-kappaB is required for inhibition of NF-kappaB by I kappaB.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980270-6

7 January 2021

Tat trans-activates the human immunodeficiency virus through a nascent RNA target

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980270-6

7 January 2021

The same inducible nuclear proteins regulates mitogen activation of both the interleukin-2 receptor-alpha gene and type 1 HIV

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980270-6

7 January 2021

Arginine-mediated RNA recognition: the arginine fork.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980270-6

7 January 2021

Does HIV-1 Tat induce a change in viral initiation rights?

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980270-6

7 January 2021

Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980270-6

7 January 2021

Activation of HIV transcription by Tat

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980270-6

7 January 2021

Independent modes of transcriptional activation by the p50 and p65 subunits of NF-kappa B

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980270-6

7 January 2021

Activation in vitro of NF-kappa B by phosphorylation of its inhibitor I kappa B

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980270-6

7 January 2021

Maintenance of NF-kappa B activity is dependent on protein synthesis and the continuous presence of external stimuli

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980270-6

7 January 2021

In vitro and in vivo binding of human immunodeficiency virus type 1 Tat protein and Sp1 transcription factor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980270-6

7 January 2021

Tat and the HIV-1 promoter

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980270-6

7 January 2021

Direct interaction of human TFIID with the HIV-1 transactivator tat

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980270-6

7 January 2021

A brain-specific transcription activator

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980270-6

7 January 2021

Multiple functional domains of Tat, the trans-activator of HIV-1, defined by mutational analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980270-6

7 January 2021

HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980270-6

7 January 2021

NF-kappa B: a family of inducible and differentially expressed enhancer-binding proteins in human T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980270-6

7 January 2021

An inducible transcription factor activates expression of human immunodeficiency virus in T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980270-6

7 January 2021

Alternative mechanisms for activation of human immunodeficiency virus enhancer in T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980270-6

7 January 2021

Lipopolysaccharide is a potent monocyte/macrophage-specific stimulator of human immunodeficiency virus type 1 expression

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980270-6

7 January 2021

HIV TAR: an RNA enhancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980270-6

7 January 2021

TAR-independent activation of HIV-1 requires the activation domain but not the RNA-binding domain of Tat.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980270-6

7 January 2021

The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980270-6

7 January 2021

RNA recognition by Tat-derived peptides: interaction in the major groove?

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980270-6

7 January 2021

trans-activation of the HIV-1 LTR by the HIV-1 Tat and HTLV-I Tax proteins is mediated by different cis-acting sequences

1 reference

https://api.crossref.org/works/10.1016%2FS0960-5428%2806%2980270-6

7 January 2021

10.1016/S0960-5428(06)80270-6

Identifiers

DOI

1 reference

22 September 2017

1 reference